Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand ...
The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This report aims to provide a ...
Russia recently claimed it has developed its own mRNA-based vaccine to combat cancer, as per Russian news agency TASS. It has been reported that the vaccine will be available for free to patients from ...
report_id=AMR1096 Opportunities in emerging markets, increased healthcare spending, and the potential for innovative product development present avenues for significant market expansion. Additionally, ...